SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Yagupsky P., Peled N., Riesenberg K., Banai M. (2000) Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area. Scand J Infect Dis 32: 315.
  • 2
    Pappas G., Memish Z.A. (2007) Brucellosis in the middle East: a persistent medical, socioeconomic and political issue. J Chemother 19: 2438.
  • 3
    Sofian M., Aghakhani A., Velayati A.A., Banifazl M., Eslamifar A., Ramezani A. (2008) Risk factors for human brucellosis in Iran: a case–control study. Int J Infect Dis 12: 15761.
  • 4
    Von Bargen K., Gorvel J.P., Salcedo S.P. (2012) Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol Rev 36: 53362.
  • 5
    Schurig G.G., Sriranganathan N., Corbel M.J. (2002) Brucellosis vaccines: past, present and future. Vet Microbiol 90: 47996.
  • 6
    Rodriguez-Zapata M., Matias M.J., Prieto A., Jonde M.A., Monserrat J., Sanchez L., Reyes E., De La Hera A., Alvarez-Mon M. (2010) Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function. Infect Immun 78: 32729.
  • 7
    Makarem E.H., Karjoo R., Omidi A. (1982) Frequency of Brucella melitensis in Southern Iran. J Trop Pediatr 28: 97100.
  • 8
    Ko J., Gendron-Fitzpatrick A., Splitter G.A. (2002) Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis. J Immunol 168: 243340.
  • 9
    Ficht T.A. (2003) Intracellular survival of Brucella: defining the link with persistence. Vet Microbiol 92: 21323.
  • 10
    Eskandari-Nasab E., Moghadampour M., Hasani S.S., Hadadi-Fishani M., Mirghanizadeh-Bafghi S.A., Asadi-Saghandi A., Zare F., Sadeghi-Kalani B., Ghazali-Bina M. (2013) Relationship between IFN-gamma gene polymorphisms and susceptibility to brucellosis infection. Microbiol Immunol 57: 78591.
  • 11
    Eskandari-Nasab E., Moghadampour M., Asadi-Saghandi A., Kharazi-Nejad E., Rezaeifar A., Pourmasoumi H. (2013) Levels of interleukin-(IL)-12p40 are markedly increased in brucellosis among patients with specific IL-12B genotypes. Scand J Immunol 78: 8591.
  • 12
    Sakai S., Kawamura I., Okazaki T., Tsuchiya K., Uchiyama R., Mitsuyama M. (2010) PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guerin. Int Immunol 22: 91525.
  • 13
    Dilmec F., Ozgonul A., Uzunkoy A., Akkafa F. (2008) Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. Int J Immunogenet 35: 31721.
  • 14
    Handa T., Nagai S., Ito I., Tabuena R., Shigematsu M., Hamada K., Kitaichi M., Izumi T., Aoyama T., Toguchida J., Mishima M. (2005) Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration 72: 2438.
  • 15
    Colonna L., Dinnall J.A., Shivers D.K., Frisoni L., Caricchio R., Gallucci S. (2006) Abnormal costimulatory phenotype and function of dendritic cells before and after the onset of severe murine lupus. Arthritis Res Ther 8: R49.
  • 16
    Nishimura Y., Shimojima M., Miyazawa T., Sato E., Nakamura K., Izumiya Y., Ikeda Y., Mikami T., Takahashi E. (2000) Molecular cloning of the cDNAs encoding the feline B-lymphocyte activation antigen B 7- 1 (CD80) and B 7- 2 (CD86) homologues which interact with human CTLA4-Ig. Eur J Immunogenet 27: 42730.
  • 17
    Liu Y., Liang W.B., Gao L.B., Pan X.M., Chen T.Y., Wang Y.Y., Xue H., Zhang L.S., Zhang L. (2010) CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease. Hum Immunol 71: 11416.
  • 18
    Macedo G.C., Magnani D.M., Carvalho N.B., Bruna-Romero O., Gazzinelli R.T., Oliveira S.C. (2008) Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J Immunol 180: 10807.
  • 19
    Skendros P., Boura P., Kamaria F., Raptopoulou-Gigi M. (2006) CD80/CD28 co-stimulation in human brucellosis. Clin Exp Immunol 146: 4008.
  • 20
    Chistiakov D.A., Turakulov R.I. (2003) CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol 31: 2136.
  • 21
    Ip W.K., Wong C.K., Leung T.F., Lam C.W. (2006) Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children. Pediatr Pulmonol 41: 67482.
  • 22
    Homann D., Dummer W., Wolfe T., Rodrigo E., Theofilopoulos A.N., Oldstone M.B., Von Herrath M.G. (2006) Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J Virol 80: 27080.
  • 23
    Sutherland R.M., Brady J.L., Georgiou H.M., Thomas H.E., Lew A.M. (2000) Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts. Transplantation 69: 180612.
  • 24
    Kristiansen O.P., Larsen Z.M., Pociot F. (2000) CTLA-4 in autoimmune diseases—a general susceptibility gene to autoimmunity? Genes Immun 1: 17084.
  • 25
    Kim S.H., Lee J.E., Jee Y.K., Kim Y.K., Park H.S., Min K.U., Park H.W. (2009) Allelic variants of CD40 and CD40L genes interact to promote antibiotic-induced cutaneous allergic reactions. Clin Exp Allergy 39: 18526.
  • 26
    Liu C.P., Jiang J.A., Wang T., Liu X.M., Gao L., Zhu R.R., Shen Y., Wu M., Xu T., Zhang X.G. (2013) CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China. Genet Mol Res 12: 137382.
  • 27
    Chen D.Q., Zeng Y., Zhou J., Yang L., Jiang S., Huang J.D., Lu L., Zheng B.J. (2010) Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population. J Med Virol 82: 3718.
  • 28
    Danilovic D.L., Mendes-Correa M.C., Lima E.U., Zambrini H., Barros R., Marui S. (2012) Correlations of CTLA-4 gene polymorphisms and hepatitis C chronic infection. Liver Int 32: 8038.
  • 29
    Domanski L., Bobrek-Lesiakowska K., Kloda K., Pawlik A., Safranow K., Wisniewska M., Romanowski M., Ciechanowski K. (2012) The impact of rs231775 (+49AG) CTLA4 gene polymorphism on transplanted kidney function. Ann Transplant 17: 2935.
  • 30
    Li Q., Wang B., Pan F., Zhang R., Xiao L., Guo H., Ma S., Zhou C. (2013) Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population: data from a multicenter study. J Gastroenterol Hepatol 28: 1397402.
  • 31
    Douroudis K., Laine A.P., Heinonen M., Hermann R., Lipponen K., Veijola R., Simell O., Knip M., Uibo R., Ilonen J., Kisand K. (2009) Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. Hum Immunol 70: 5369.
  • 32
    Benhatchi K., Jochmanova I., Habalova V., Wagnerova H., Lazurova I. (2011) CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis-results and the review of the literature. Clin Rheumatol 30: 131924.
  • 33
    Blomhoff A., Lie B.A., Myhre A.G., Kemp E.H., Weetman A.P., Akselsen H.E., Huseby E.S., Undlien D.E. (2004) Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 89: 34746.
  • 34
    Heggarty S., Suppiah V., Silversides J., O'doherty C., Droogan A., Mcdonnell G., Hawkins S., Graham C., Vandenbroeck K. (2007) CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland. J Neuroimmunol 187: 18791.
  • 35
    Parks C.G., Hudson L.L., Cooper G.S., Dooley M.A., Treadwell E.L., St Clair E.W., Gilkeson G.S., Pandey J.P. (2004) CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. Lupus 13: 78491.
  • 36
    Xu H., Zhao M., He J., Chen Z. (2013) Association between cytotoxic T-lymphocyte associated protein 4 gene +49 A/G polymorphism and chronic infection with hepatitis B virus: a meta-analysis. J Int Med Res 41: 55967.
  • 37
    Khorshied M.M., Gouda H.M., Khorshid O.M. (2013) Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study. Leuk Lymphoma [Epub ahead of print].
  • 38
    Lozano V.F., Lins T.C., Teixeira M.M., Vieira R.G., Blotta M.H., Goes A.M., Silva I.C., Pereira R.W., Bocca A.L., Felipe M.S. (2011) Polymorphism analysis of the CTLA-4 gene in paracoccidioidomycosis patients. Mem Inst Oswaldo Cruz 106: 2206.
  • 39
    Wiart A., Jepson A., Banya W., Bennett S., Whittle H., Martin N.G., Hill A.V. (2004) Quantitative association tests of immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Twin Res 7: 57888.
  • 40
    Wang C., Jiang T., Wei L., Li F., Sun X., Fan D., Liu J., Zhang X., Xu D., Chen Z., Li Z., Fu X., Li J.C. (2012) Association of CTLA4 gene polymorphisms with susceptibility and pathology correlation to pulmonary tuberculosis in Southern Han Chinese. Int J Biol Sci 8: 94552.
  • 41
    Thye T., Scarisbrick G., Browne E.N., Chinbuah M.A., Gyapong J., Osei I., Owusu-Dabo E., Niemann S., Rusch-Gerdes S., Meyer C.G., Horstmann R.D. (2009) CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an African population. PLoS ONE 4: e6307.
  • 42
    Ma X.N., Wang X., Yan Y.Y., Yang L., Zhang D.L., Sheng X., Liu X.M., Huang H., Dai J., Zhong Y.J., Liao L.C. (2010) Absence of association between CD86 +1057G/A polymorphism and coronary artery disease. DNA Cell Biol 29: 3258.
  • 43
    El-Koumi M.A., Afify M., Al-Zahrani S.H. (2013) A prospective study of brucellosis in children: relative frequency of pancytopenia. Mediterr J Hematol Infect Dis 5: e2013011.
  • 44
    Mukherjee F., Jain J., Patel V., Nair M. (2007) Multiple genus-specific markers in PCR assays improve the specificity and sensitivity of diagnosis of brucellosis in field animals. J Med Microbiol 56: 130916.
  • 45
    Eskandari-Nasab E., Hashemi M., Rezaei H., Fazaeli A., Mashhadi M.A., Moghaddam S.S., Arbabi F., Jahantigh M., Taheri M. (2012) Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Mol Biol Rep 39: 105319.
  • 46
    Balbi G., Ferrera F., Rizzi M., Piccioli P., Morabito A., Cardamone L., Ghio M., Palmisano G.L., Carrara P., Pedemonte S., Sessarego M., De Angioletti M., Notaro R., Indiveri F., Pistillo M.P. (2007) Association of (318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clin Exp Immunol 149: 407.
  • 47
    Xiang H., Zhao W., Sun Y., Qian W., Xing J., Zhou Y., Yao J., Xu J., Wang Y., Yao H., Hu Z. (2012) CD86 gene variants and susceptibility to pancreatic cancer. J Cancer Res Clin Oncol 138: 20617.
  • 48
    Sole X., Guino E., Valls J., Iniesta R., Moreno V. (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 19289.
  • 49
    Lewontin R.C. (1995) The detection of linkage disequilibrium in molecular sequence data. Genetics 140: 37788.
  • 50
    Oliveira S.C., Soeurt N., Splitter G. (2002) Molecular and cellular interactions between Brucella abortus antigens and host immune responses. Vet Microbiol 90: 41724.
  • 51
    Baldwin C.L., Goenka R. (2006) Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol 26: 40742.
  • 52
    Skendros P., Sarantopoulos A., Tselios K., Boura P. (2008) Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs. Clin Dev Immunol 2008: 3276.
  • 53
    Su T.H., Chang T.Y., Lee Y.J., Chen C.K., Liu H.F., Chu C.C., Lin M., Wang P.T., Huang W.C., Chen T.C., Yang Y.C. (2007) CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 28: 123740.
  • 54
    Benmansour J., Stayoussef M., Al-Jenaidi F.A., Rajab M.H., Rayana C.B., Said H.B., Mahjoub T., Almawi W.Y. (2010) Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians. Clin Vaccine Immunol 17: 14737.
  • 55
    Lemos M.C., Coutinho E., Gomes L., Bastos M., Fagulha A., Barros L., Carrilho F., Geraldes E., Regateiro F.J., Carvalheiro M. (2009) The CTLA4 +49 A/G polymorphism is not associated with susceptibility to type 1 diabetes mellitus in the Portuguese population. Int J Immunogenet 36: 1935.
  • 56
    Fernandez-Mestre M., Sanchez K., Balbas O., Gendzekhzadze K., Ogando V., Cabrera M., Layrisse Z. (2009) Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases. Hum Immunol 70: 5325.
  • 57
    Du L., Yang J., Huang J., Ma Y., Wang H., Xiong T., Xiang Z., Zhang Y. (2013) The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population. BMC Med Genet 14: 46.
  • 58
    Martin T.M., Bye L., Modi N., Stanford M.R., Vaughan R., Smith J.R., Wade N.K., Mackensen F., Suhler E.B., Rosenbaum J.T., Wallace G.R. (2009) Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort. Mol Vis 15: 20812.
  • 59
    De Almeida E.R., Petzl-Erler M.L. (2013) Expression of genes involved in susceptibility to multifactorial autoimmune diseases: estimating genotype effects. Int J Immunogenet 40: 17885.
  • 60
    Zhang Y.J., Xu W.D., Duan Z.H., Liu S.S., Pan H.F., Ye D.Q. (2012) Lack of association between CTLA-4 +49A/G and (318 C/T polymorphisms and Behcet's disease risk: a meta-analysis. Clin Exp Rheumatol 30: S4650.
  • 61
    Torres-Carrillo N., Ontiveros-Mercado H., Torres-Carrillo N.M., Parra-Rojas I., Rangel-Villalobos H., Ramirez-Duenas M.G., Gutierrez-Urena S.R., Valle Y., Munoz-Valle J.F. (2013) The (319C/+ 49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population. Cell Biochem Biophys 67: 121728.
  • 62
    Liu J., Zhang H. (2013) (1722T/C polymorphism (rs733618) of CTLA-4 significantly associated with systemic lupus erythematosus (SLE): a comprehensive meta-analysis. Hum Immunol 74: 3417.
  • 63
    Li M., Zheng H., Li T., Gao P., Zhang X.L., Liu D.W. (2012) Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: a systematic review. J Gastroenterol Hepatol 27: 115966.
  • 64
    Marin L.A., Moya-Quiles M.R., Miras M., Muro M., Minguela A., Bermejo J., Ramirez P., Garcia-Alonso A.M., Parrilla P., Alvarez-Lopez M.R. (2005) Evaluation of CD86 gene polymorphism at +1057 position in liver transplant recipients. Transpl Immunol 15: 6974.
  • 65
    Matsushita M., Tsuchiya N., Oka T., Yamane A., Tokunaga K. (2000) New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus. Genes Immun 1: 42834.
  • 66
    Wang J., Zhou Y., Feng D., Yang H., Li F., Cao Q., Wang A., Xing F. (2012) CD86 + 1057G/A polymorphism and susceptibility to Ewing's sarcoma: a case–control study. DNA Cell Biol 31: 53740.
  • 67
    Aiba Y., Nakamura M., Joshita S., Inamine T., Komori A., Yoshizawa K., Umemura T., Horie H., Migita K., Yatsuhashi H., Nakamuta M., Fukushima N., Saoshiro T., Hayashi S., Kouno H., Ota H., Muro T., Watanabe Y., Nakamura Y., Komeda T., Shimada M., Masaki N., Komatsu T., Yagura M., Sugi K., Koga M., Tsukamoto K., Tanaka E., Ishibashi H. (2011) Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. J Gastroenterol 46: 120312.
  • 68
    Joshita S., Umemura T., Yoshizawa K., Katsuyama Y., Tanaka E., Nakamura M., Ishibashi H., Ota M. (2010) Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients. J Hepatol 53: 53741.